Patents by Inventor Doris Guenzi COIT

Doris Guenzi COIT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10753939
    Abstract: Modified hepatitis C virus polypeptides are described. The polypeptides include the HCV NS4a domain and modified NS3 domain. The polypeptides retain conformational epitopes. HCV immunoassays including the polypeptides are also described.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: August 25, 2020
    Assignees: ORTHO-CLINICAL DIAGNOSTICS, INC., GRIFOLS WORLDWIDE OPERATIONS LIMITED, ORTHO CLINICAL DIAGNOSTICS, K.K
    Inventors: David Y. Chien, Doris Guenzi Coit, Toshiya Fujihara, Alexander Gyenes, John Andrew Hall, Angelica Medina-Selby, Jian Zheng
  • Publication number: 20190271700
    Abstract: Modified hepatitis C virus polypeptides are described. The polypeptides include the HCV NS4a domain and modified NS3 domain. The polypeptides retain conformational epitopes. HCV immunoassays including the polypeptides are also described.
    Type: Application
    Filed: March 8, 2019
    Publication date: September 5, 2019
    Inventors: David Y. Chien, Doris Guenzi Coit, Toshiya Fujihara, Alexander Gyenes, John Andrew Hall, Angelica Medina-Selby, Jian Zheng
  • Patent number: 10267803
    Abstract: Modified hepatitis C virus polypeptides are described. The polypeptides include the HCV NS4a domain and modified NS3 domain. The polypeptides retain conformational epitopes. HCV immunoassays including the polypeptides are also described.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: April 23, 2019
    Assignee: ORTHO-CLINICAL DIAGNOSTICS, INC.
    Inventors: David Y. Chien, Doris Guenzi Coit, Toshiya Fujihara, Alexander Gyenes, John Andrew Hall, Angelica Medina-Selby, Jian Zheng
  • Publication number: 20180011096
    Abstract: Modified hepatitis C virus polypeptides are described. The polypeptides include the HCV NS4a domain and modified NS3 domain. The polypeptides retain conformational epitopes. HCV immunoassays including the polypeptides are also described.
    Type: Application
    Filed: June 22, 2015
    Publication date: January 11, 2018
    Inventors: David Y. CHIEN, Doris Guenzi COIT, Toshiya FUJIHARA, Alexander GYENES, John Andrew HALL, Angelica MEDINA-SELBY, Jian ZHENG